Ontology highlight
ABSTRACT:
INSTRUMENT(S): LTQ
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): Epithelial Cell, Cell Culture
DISEASE(S): Breast Cancer
SUBMITTER: Irineos Papakyriacou
LAB HEAD: Yumeng Mao
PROVIDER: PXD051061 | Pride | 2024-06-23
REPOSITORIES: Pride
Papakyriacou Irineos I Kutkaite Ginte G Rúbies Bedós Marta M Nagarajan Divya D Alford Liam P LP Menden Michael P MP Mao Yumeng Y
Nature communications 20240427 1
Immune checkpoint blockade therapy aims to activate the immune system to eliminate cancer cells. However, clinical benefits are only recorded in a subset of patients. Here, we leverage genome-wide CRISPR/Cas9 screens in a Tumor-Immune co-Culture System focusing on triple-negative breast cancer (TNBC). We reveal that NEDD8 loss in cancer cells causes a vulnerability to nivolumab (anti-PD-1). Genetic deletion of NEDD8 only delays cell division initially but cell proliferation is unaffected after r ...[more]